Abstract
The object of this chapter is to describe the covalent chemistry of pancreatic glucagon to provide a background for subsequent chapters. Modifications of the primary structure are considered with respect to biologic activity, but not immunologic activity which is discussed in Chap. 9. Conformation and function are considered in Chap. 3.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Assan R, Delaunay J (1972) Activités biologiques comparées de différents glucagons-retard et de glucagon ordinaire. Pathol Biol (Paris) 20: 979–984
Assan R, Slusher N (1972) Structure/function and structure/immunoreactivity relationships of the glucagon molecule and related synthetic peptides. Diabetes 16: 843–855
Beaven GH, Gratzer WB, Davies HG (1969) Formation and structure of gels and fibrils from glucagon. Eur J Biochem 11: 37–42
Biemond MEF, Sipman WA, Olivie J (1979) Quantitative determination of polypeptides by gradient elution high pressure liquid chromatography. J Liq Chromatogr 2: 1407–1435
Birnbaumer L, Pohl SL (1973) Relation of glucagon-specific binding sites to glucagon-de- pendent stimulation of adenylyl cyclase activity in plasma membranes of rat liver. J Biol Chem 248: 2056–2061
Bregman MD, Hruby VJ (1979) Synthesis and isolation of a glucagon antagonist. FEBS Letters 101: 191–194
Bregman MD, Levy D (1977) Labeling of glucagon binding components in hepatocyte plasma membranes. Biochem Biophys Res Commun 78: 584–590
Bregman MD, Cheng S, Levy D (1978) Synthesis and properties of a photoaffinity probe for the glucagon receptor in hepatocyte plasma membranes. Biochim Biophys Acta 539: 489–495
Bregman MD, Trivedi D, Hruby VJ (1980) Glucagon amino groups: evaluation of modifi-cations leading to antagonism and agonism. J Biol Chem 255: 11725–11731
Bromer WW (1976) Studies with glucagon analogs. Metabolism [Suppl 1] 25: 1315–1316
Bromer WW, Chance RE (1969) Zinc glucagon depression of blood amino acids in rabbits. Diabetes 18: 748–754
Bromer WW, Sinn LG, Staub A, Behrens OK (1956) The amino acid sequence of glucagon. J Am Chem Soc 78: 3858–3859
Bromer WW, Staub A, Diller ER, Bird HL, Sinn LG, Behrens OK (1957) The amino acid sequence of glucagon. I. the amino acid composition and terminal amino acid analyses. J Am Chem Soc 79: 2794–2798
Bromer WW, Boucher ME, Koffenberger JE (1971) Amino acid sequence of bovine glucagon. J Biol Chem 246: 2822–2827
Bromer WW, Boucher ME, Patterson JM, Pekar AH, Frank BH (1972) Glucagon structure and function. I. Purification and properties of bovine glucagon and monodesamidoglucagon. J Biol Chem 247: 2581–2585
Bromer WW, Boucher ME, Patterson JM (1973) Glucagon structure and function. II. Increased activity of iodoglucagon. Biochem Biophys Res Commun 53: 134–139
Cole RD (1960) Ion exchange chromatography of glucagon in urea-containing buffers. J Biol Chem 235: 2300–2301
Contaxis CC, Epand RM (1974) A study of the conformational properties of glucagon in the presence of glycols. Can J Biochem 52: 456–468
Cote TE, Epand RM (1979) Nα-trinitrophenylglucagon. An inhibition of glucagon-stimulated cyclic AMP production and its effects on glycogenolysis. Biochim Biophys Acta 582: 295–306
Demoliou CD, Epand RM (1980) Synthesis and characterization of a heterobifunctional photoaffinity reagent for modification of tryptophan residues and its application to the preparation of a photoreactive glucagon derivative. Biochemistry 19: 4539–4546
Desbuquois B (1975a) Acetylglucagon: preparation and characterization. Eur J Biochem 60: 335–347
Desbuquois B (1975b) Iodoglucagon: preparation and characterization. Eur J Biochem 53: 569–580
Desbuquois B, Laudat M-H (1974) Glucagon-receptor interactions in fat cell membranes. Mol Cell Endocrinol 1: 355–370
England RD, Gurd RS (1980) Structure-function relationships in glucagon: a comparative study of four COOH-terminal derivatives ( Abstr ). Clin Res 28: 798
Epand R (1980) The activation of adenylate cyclase by chemically modified forms of glucagon and its relationship to receptor binding. In: Brandenburg D, Wollmer A (eds) Insulin: Chemistry, structure, and function of insulin and related hormones, de Gruyter, Berlin New York, p 363
Epand RM, Wheeler GE (1975) Conformational and biological properties of a glucagon derivative with enhanced biological activity (Abstr) Fed Proc 34: 660
Epand RM, Cote TE, Hoa DHB, Rosselin G, Schreier S (1976) Biologic activity and conformational properties of glucagon and glucagon analogs. Metabolism [Suppl 1] 25: 1317–1318
Epand RM, Rosselin G, Hoa DHB, Cote TE, Laburthe M (1981) Structural requirements for glucagon receptor binding and activation of adenylate cyclase in liver. J Biol Chem 256:1128–1132
Felts DW, Ferguson MEC, Hagey KA, Stitt ES, Mitchell WM (1970) Studies on the struc-ture-function relationships of glucagon ( Abstr ). Diabetologia 6: 44–45
Grande F, Grisola S, Diederich D (1972) On the biological and chemical reactivity of car- bamylated glucagon. Proc Soc Exp Biol Med 139: 855–860
Gratzer WB, Bailey E, Beaven GH (1967) Conformational states of glucagon. Biochem Biophys Res Commun 28: 914–919
Guy-Grand B, Assan R (1973) Lipolytic responses of human adipose tissue in vitro to natural glucagon and to synthetic [1–23] glucagon peptide (Abstr). Diabetologia 9:70 Hancock WS, Bishop CA, Prestidge RL, Harding DRK, Hearn MTW (1978) Reversed- phase, high-pressure liquid chromatography of peptides and proteins with ion-pairing reagents. Science 200: 1168–1170
Hruby VJ (1982) Structure-conformation-activity studies of glucagon and semi-synthetic glucagon analogs. Mol Cell Biochem 44:49–64
Hruby VJ, Groginsky CM (1971) Partition chromatography of glucagon and secretin on sephadex. J Chromatogr 63: 423–428
Hruby VJ, Wright DE, Lin MC, Rodbell M (1976) Semisynthetic glucagon derivatives for structure-function studies. Metabolism [Suppl 1] 25: 1323–1325
Jones BN, Gurd RS (1981) Ultrapure cyanogen bromide-cleaved glucagon: isolation in high yield by ion exchange chromatography. Arch Biochem Biophys 206: 227–331
Kenny AJ (1955) Extractable glucagon of the human pancreas. J Clin Endocrinol Metab 15: 1089–1105
Lande S, Gorman R, Bitensky M (1972) SelectiSvely blocked and des-histidine-glucagons: preparation and effects on hepatic adenylate cyclase activity. Endocrinology 90: 597–604
Lin MC, Wright DE, Hruby VJ, Rodbell M (1975) Structure-function relationships in glucagon: properties of highly purified des HisVmonoiodo-, and [desAsn28,Thr29] (homoserine lactone27)-glucagon. Biochemistry 14: 1559–1563
Lin MC, Nicosia S, Rodbell M (1976) Effects of iodination of tyrosyl residues on the binding and action of glucagon at its receptor. Biochemistry 15: 4537–4540
Lin MC, Nicosia S, Lad PM, Rodbell M (1977) Effects of GTP on binding of [3H]glucagon to receptors in rat hepatic plasma membranes. J Biol Chem 252: 2790–2792
Lochner JdeV, Esterhuizen AC, Unger RH (1964) Separation of human insulin, glucagon, and other pancreatic proteins. Diabetes 13: 387–394
Markussen J, Frandsen E, Heding LG, Sundby F (1972) Turkey glucagon: crystallization, amino acid composition and immunology. Horm Metab Res 4: 360–363
McDonald JK, Callahan PX, Zeitman BB, Ellis S (1969) Inactivation and degradation of glucagon by dipeptidyl aminopeptidase I (cathepsin C) of rat liver. J Biol Chem 244: 6199–6208
Mitznegg P, Domschke W, Domschke S, Sprugel W, Estler C-J, Wunsch E, Jaeger E, Demling L (1976) Effect of glucagon and its 1-23 peptide fragment on lipolysis in isolated rat and human fat cells. Biochem Pharmacol 25: 210–211
Nooijen WJ, Kempen HJ (1979) Immunogenicity and bioactivity of glucagon, modified at methionine-27. Horm Metab Res 11: 459–463
Patterson JM, Bromer WW (1973) Glucagon structure and function: preparation and characterization of nitroglucagon and aminoglucagon. J Biol Chem 248: 8337–8342
Pohl SL, Krans HMJ, Birnbaumer L, Rodbell M (1972) Inactivation of glucagon by plasma membranes of rat liver. J Biol Chem 247: 2295–2301
Pollock HG, Kimmel JR (1975) Chicken glucagon. Isolation and amino acid sequence studies. J Biol Chem 250: 9377–9380
Rhoten WB (1976) Glucagon levels in pancreatic extracts and plasma of the lizard. Am J Anat 147: 131–137
Rodbell M, Krans HMJ, Pohl SL, Birnbaumer L (1971a) The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. J Biol Chem 246: 1861–1871
Rodbell M, Birnbaumer L, Pohl SL, Sundby F (1971b) The reaction of glucagon with its receptor: evidence for discrete regions of activity and binding in the glucagon molecule. Proc Natl Acad Sci USA 68: 909–913
Rodbell M, Lin MC, Salomon Y (1974) Evidence for interdependent action of glucagon and nucleotides on the hepatic adenylate cyclase systems. J Biol Chem 249: 59–65
Rosselin G, Freychet P, Fouchereau M, Rancon F, Broer Y (1974) Interactions of insulin and glucagon with isolated rat liver cells II - Dynamic changes in the cyclic AMP induced by hormones. Horm Metab Res 5: 78–86
Rothgeb MT, Jones BN, Hayes DF, Gurd RS (1977) Methylation of glucagon, character-ization of the sulfonium derivative, and regeneration of the native covalent structure. Biochemistry 16: 5813–5818
Sokal JE (1960) The duration of glucagon effect. Endocrinology 67: 774–783
Sonne O, Berg T, Christoffersen T (1978) Binding of 125I-labeled glucagon and glucagon- stimulated accumulation of adenosine 3’: 5’-monophosphate in isolated intact rat he- patocytes. Evidence for receptor heterogeneity. J Biol Chem 253: 3203–3210
Staub F, Sinn L, Behrens OK (1955) Purification and crystallization of glucagon. J Biol Chem 214: 619–632
Sundby F (1976) Species variation in the primary structure of glucagon. Metabolism [Suppl 1] 25: 1319–1321
Sundby F, Markussen J (1971) Isolation crystallization and amino acid composition of rat glucagon. Horm Metab Res 3: 184–187
Sundby F, Markussen J (1972) Rabbit glucagon: isolation, crystallization and amino acid composition. Horm Metab Res 4: 56
Sundby F, Frandsen EK, Thomsen J, Kristiansen K, Brunfeldt K (1972) Crystallization and amino acid sequence of duck glucagon. FEBS Lett 26: 289–293
Sundby F, Markussen J, Danho W (1974) Camel glucagon: isolation, crystallization and amino acid composition. Horm Metab Res 6: 425
Sutherland EW, deDuve C (1948) Origin and distribution of the hyperglycemic-glycogenolytic factor of the pancreas. J Biol Chem 175:663–674
Tallarida RJ, Jacob LS (1979) The dose-response relation in pharmacology, 1st edn.Springer, Berlin Heidelberg New York
Tarding F, Nielsen P, Pingel M, Volund Aa (1969) Biological and chemical properties of two glucagon preparations with prolonged action. Eur J Pharmacol 7: 206–210
Thomsen J, Kristiansen K, Brunfeldt K (1972) The amino acid sequence of human glucagon. FEBS Lett 21: 315–319
Trakatellis AC, Tada K, Yamaji K, Gardiki-Kouidou P (1975) Isolation and partial characterization of anglerflsh proglucagon. Biochemistry 14: 1508–1512
Weinges KF (1959) Der Einfluβ eines protrahiert wirkenden Glucagons auf den Blutzucker, das anorganische Serumphosphat und die Gesamtaminosauren im Serum. Naunyn Schmiedebergs Arch Pharmacol 237: 22–26
Wheeler GE, Epand RM, Barrett D (1974) Non-equivelance of the carboxyl groups of glucagon in the carbodiimide-promoted reaction with nucleophiles and the role of carboxyl groups in the ability of glucagon to stimulate adenyl cyclase of rat liver. Biochim Biophys Acta 372: 440–449
Wright DE, Rodbell M (1979) Glucagon 1-6 binds to the glucagon receptor and activates hepatic adenylate cyclase. J Biol Chem 254: 268–269
Wright DE, Hruby VJ, Rodbell M (1978) A reassessment of structure-function relationships in glucagon: glucagon-2i is a full agonist. J Biol Chem 253: 6338–6340
Wright DE, Hruby VJ, Rodbell M (1980) Preparation and properties of glucagon analogs prepared by semi-synthesis from CNBr-glucagon. Biochim Biophys Acta 631: 49–58
Ziegler M, Lippmann HG (1968) Quantitative electrophoretic separation of insulin and glucagon. Naturwissenschaften 55: 181
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bromer, W.W. (1983). Chemical Characteristics of Glucagon. In: Lefèbvre, P.J. (eds) Glucagon I. Handbook of Experimental Pharmacology, vol 66 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68866-9_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-68866-9_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-68868-3
Online ISBN: 978-3-642-68866-9
eBook Packages: Springer Book Archive